Skip to main content

Advertisement

Fig. 7 | SpringerPlus

Fig. 7

From: Discovery of the molecular mechanisms of the novel chalcone-based Magnaporthe oryzae inhibitor C1 using transcriptomic profiling and co-expression network analysis

Fig. 7

Validation of the microarray results by qRT-PCR and Western blot. a Values indicate the relative fold-change between the groups (drug treated vs. control group) detected by microarray (black) or qRT-PCR (blue); b the Western blot analysis of P450, NMT and PXMP4 protein expression levels after drug treatment

Back to article page